Medline Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Cap	53,914	34,104	-	-	-
Enterprise Value	64,283	53,275	0	0	0
Last Close Price	41.04	42.00	-	-	-
PS Ratio	1.85	1.20	-	-	-
PB Ratio	3.08	3.18	-	-	-
P/FCF Ratio	54.13	26.29	-	-	-
P/OCF Ratio	36.58	19.56	-	-	-
EV/Sales Ratio	2.21	1.87	-	-	-
EV/EBITDA Ratio	21.12	16.53	-	-	-
EV/EBIT Ratio	31.73	24.08	-	-	-
EV/FCF Ratio	64.54	41.08	-	-	-
Debt / Equity Ratio	0.65	0.65	0.99	0.97	-
Debt / EBITDA Ratio	4.08	3.90	5.28	7.50	-
Debt / FCF Ratio	12.22	9.69	11.66	11.71	-
Net Debt / Equity Ratio	0.92	0.99	1.01	0.89	-
Net Debt / EBITDA Ratio	3.36	3.30	5.22	6.80	-
Net Debt / FCF Ratio	10.05	8.19	11.52	10.61	-
Asset Turnover	0.75	0.76	0.71	1.29	-
Inventory Turnover	4.51	4.53	4.48	9.10	-
Quick Ratio	2.33	2.20	1.40	2.12	-
Current Ratio	4.41	4.29	3.39	4.13	-
Return on Equity (ROE)	5.56%	6.46%	7.16%	2.76%	-
Return on Assets (ROA)	4.76%	5.51%	5.73%	6.13%	-
Return on Invested Capital (ROIC)	6.19%	6.54%	6.38%	3.47%	-
Return on Capital Employed (ROCE)	5.69%	6.36%	6.36%	7.35%	-
FCF Yield	1.85%	3.80%	-	-	-
Dividend Yield	-	1.52%	-	-	-
Payout Ratio	-	44.69%	126.50%	48.72%	-92.00%
Total Shareholder Return	-	1.52%	-	-	-

SEC Filings: 10-K · 10-Q